Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Skin Disease Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Skin Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Skin Disease Treatment Overall Market Size
2.1 Global Skin Disease Treatment Market Size: 2021 VS 2028
2.2 Global Skin Disease Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Skin Disease Treatment Players in Global Market
3.2 Top Global Skin Disease Treatment Companies Ranked by Revenue
3.3 Global Skin Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Skin Disease Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Skin Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Skin Disease Treatment Players in Global Market
3.6.1 List of Global Tier 1 Skin Disease Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Skin Disease Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Skin Disease Treatment Market Size Markets, 2021 & 2028
4.1.2 Medicated Creams and Ointments
4.1.3 Antibiotics
4.1.4 Vitamins and Steroids
4.1.5 Antihistamines
4.1.6 Laser Therapy
4.1.7 Antifungals
4.1.8 Others
4.2 By Type - Global Skin Disease Treatment Revenue & Forecasts
4.2.1 By Type - Global Skin Disease Treatment Revenue, 2017-2022
4.2.2 By Type - Global Skin Disease Treatment Revenue, 2023-2028
4.2.3 By Type - Global Skin Disease Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Skin Disease Treatment Market Size, 2021 & 2028
5.1.2 Dermatology Clinics
5.1.3 Skincare Clinics
5.1.4 Hospitals
5.1.5 Aesthetic Centers
5.1.6 Others
5.2 By Application - Global Skin Disease Treatment Revenue & Forecasts
5.2.1 By Application - Global Skin Disease Treatment Revenue, 2017-2022
5.2.2 By Application - Global Skin Disease Treatment Revenue, 2023-2028
5.2.3 By Application - Global Skin Disease Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Skin Disease Treatment Market Size, 2021 & 2028
6.2 By Region - Global Skin Disease Treatment Revenue & Forecasts
6.2.1 By Region - Global Skin Disease Treatment Revenue, 2017-2022
6.2.2 By Region - Global Skin Disease Treatment Revenue, 2023-2028
6.2.3 By Region - Global Skin Disease Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Skin Disease Treatment Revenue, 2017-2028
6.3.2 US Skin Disease Treatment Market Size, 2017-2028
6.3.3 Canada Skin Disease Treatment Market Size, 2017-2028
6.3.4 Mexico Skin Disease Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Skin Disease Treatment Revenue, 2017-2028
6.4.2 Germany Skin Disease Treatment Market Size, 2017-2028
6.4.3 France Skin Disease Treatment Market Size, 2017-2028
6.4.4 U.K. Skin Disease Treatment Market Size, 2017-2028
6.4.5 Italy Skin Disease Treatment Market Size, 2017-2028
6.4.6 Russia Skin Disease Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Skin Disease Treatment Market Size, 2017-2028
6.4.8 Benelux Skin Disease Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Skin Disease Treatment Revenue, 2017-2028
6.5.2 China Skin Disease Treatment Market Size, 2017-2028
6.5.3 Japan Skin Disease Treatment Market Size, 2017-2028
6.5.4 South Korea Skin Disease Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Skin Disease Treatment Market Size, 2017-2028
6.5.6 India Skin Disease Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Skin Disease Treatment Revenue, 2017-2028
6.6.2 Brazil Skin Disease Treatment Market Size, 2017-2028
6.6.3 Argentina Skin Disease Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Skin Disease Treatment Revenue, 2017-2028
6.7.2 Turkey Skin Disease Treatment Market Size, 2017-2028
6.7.3 Israel Skin Disease Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Skin Disease Treatment Market Size, 2017-2028
6.7.5 UAE Skin Disease Treatment Market Size, 2017-2028
7 Players Profiles
7.1 APEIRON Biologics AG
7.1.1 APEIRON Biologics AG Corporate Summary
7.1.2 APEIRON Biologics AG Business Overview
7.1.3 APEIRON Biologics AG Skin Disease Treatment Major Product Offerings
7.1.4 APEIRON Biologics AG Skin Disease Treatment Revenue in Global Market (2017-2022)
7.1.5 APEIRON Biologics AG Key News
7.2 HanAll BioPharma
7.2.1 HanAll BioPharma Corporate Summary
7.2.2 HanAll BioPharma Business Overview
7.2.3 HanAll BioPharma Skin Disease Treatment Major Product Offerings
7.2.4 HanAll BioPharma Skin Disease Treatment Revenue in Global Market (2017-2022)
7.2.5 HanAll BioPharma Key News
7.3 GlaxoSmithKline plc.
7.3.1 GlaxoSmithKline plc. Corporate Summary
7.3.2 GlaxoSmithKline plc. Business Overview
7.3.3 GlaxoSmithKline plc. Skin Disease Treatment Major Product Offerings
7.3.4 GlaxoSmithKline plc. Skin Disease Treatment Revenue in Global Market (2017-2022)
7.3.5 GlaxoSmithKline plc. Key News
7.4 Allergen, Plc.
7.4.1 Allergen, Plc. Corporate Summary
7.4.2 Allergen, Plc. Business Overview
7.4.3 Allergen, Plc. Skin Disease Treatment Major Product Offerings
7.4.4 Allergen, Plc. Skin Disease Treatment Revenue in Global Market (2017-2022)
7.4.5 Allergen, Plc. Key News
7.5 Anacor Pharmaceuticals
7.5.1 Anacor Pharmaceuticals Corporate Summary
7.5.2 Anacor Pharmaceuticals Business Overview
7.5.3 Anacor Pharmaceuticals Skin Disease Treatment Major Product Offerings
7.5.4 Anacor Pharmaceuticals Skin Disease Treatment Revenue in Global Market (2017-2022)
7.5.5 Anacor Pharmaceuticals Key News
7.6 Celgene
7.6.1 Celgene Corporate Summary
7.6.2 Celgene Business Overview
7.6.3 Celgene Skin Disease Treatment Major Product Offerings
7.6.4 Celgene Skin Disease Treatment Revenue in Global Market (2017-2022)
7.6.5 Celgene Key News
7.7 Basilea Pharmaceutica
7.7.1 Basilea Pharmaceutica Corporate Summary
7.7.2 Basilea Pharmaceutica Business Overview
7.7.3 Basilea Pharmaceutica Skin Disease Treatment Major Product Offerings
7.7.4 Basilea Pharmaceutica Skin Disease Treatment Revenue in Global Market (2017-2022)
7.7.5 Basilea Pharmaceutica Key News
7.8 Cipher Pharmaceuticals
7.8.1 Cipher Pharmaceuticals Corporate Summary
7.8.2 Cipher Pharmaceuticals Business Overview
7.8.3 Cipher Pharmaceuticals Skin Disease Treatment Major Product Offerings
7.8.4 Cipher Pharmaceuticals Skin Disease Treatment Revenue in Global Market (2017-2022)
7.8.5 Cipher Pharmaceuticals Key News
7.9 Agenus
7.9.1 Agenus Corporate Summary
7.9.2 Agenus Business Overview
7.9.3 Agenus Skin Disease Treatment Major Product Offerings
7.9.4 Agenus Skin Disease Treatment Revenue in Global Market (2017-2022)
7.9.5 Agenus Key News
7.10 Astion Pharma A/S
7.10.1 Astion Pharma A/S Corporate Summary
7.10.2 Astion Pharma A/S Business Overview
7.10.3 Astion Pharma A/S Skin Disease Treatment Major Product Offerings
7.10.4 Astion Pharma A/S Skin Disease Treatment Revenue in Global Market (2017-2022)
7.10.5 Astion Pharma A/S Key News
7.11 Bristol-Myers Squibb
7.11.1 Bristol-Myers Squibb Corporate Summary
7.11.2 Bristol-Myers Squibb Business Overview
7.11.3 Bristol-Myers Squibb Skin Disease Treatment Major Product Offerings
7.11.4 Bristol-Myers Squibb Skin Disease Treatment Revenue in Global Market (2017-2022)
7.11.5 Bristol-Myers Squibb Key News
7.12 Almirall S.A.
7.12.1 Almirall S.A. Corporate Summary
7.12.2 Almirall S.A. Business Overview
7.12.3 Almirall S.A. Skin Disease Treatment Major Product Offerings
7.12.4 Almirall S.A. Skin Disease Treatment Revenue in Global Market (2017-2022)
7.12.5 Almirall S.A. Key News
7.13 Galderma
7.13.1 Galderma Corporate Summary
7.13.2 Galderma Business Overview
7.13.3 Galderma Skin Disease Treatment Major Product Offerings
7.13.4 Galderma Skin Disease Treatment Revenue in Global Market (2017-2022)
7.13.5 Galderma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer